侵袭性垂体神经内分泌肿瘤呈现独特免疫微环境
侵袭性PitNET较非侵袭性者CD3 T淋巴细胞和CD163巨噬细胞浸润更高,IFN-γ和PDGFAA表达更低;CD163升高与肿瘤复发相关,IL8和TGFβ升高与死于垂体疾病相关。
要点
- 侵袭性PitNET免疫微环境以CD3 T细胞和CD163巨噬细胞浸润增加为特征。
- CD163升高与肿瘤复发相关,IL8和TGFβ升高与死于垂体疾病相关。
- Pit1和TPit型PitNET更常见血管周围免疫细胞浸润模式。
核心结论
- 侵袭性PitNET呈现以免疫细胞浸润增加为特征的独特肿瘤微环境,可能提供新的预后生物标志物和治疗靶点。
研究设计与样本
- 采用免疫组化分析免疫细胞、免疫检查点和细胞周期调控/衰老标志物,采用多重免疫分析检测细胞因子和趋化因子。
主要发现
- 侵袭性PitNET较非侵袭性PitNET有更高的CD3 T淋巴细胞和CD163巨噬细胞浸润,以及更低的IFN-γ和PDGFAA表达。
- 在Pit1型PitNET中,侵袭性较SF1型PitNET也观察到上述免疫浸润差异。
- 侵袭性和非侵袭性Pit1型PitNET均较SF1型PitNET表达更高的检查点标志物PDL1和衰老标志物p16、p21。
- Pit1和TPit型PitNET较SF1型PitNET更常见血管周围免疫细胞浸润模式。
- MIG、MIP1β和IL1RA与T淋巴细胞、树突状细胞和CD163巨噬细胞正相关;CD163升高与肿瘤复发相关,IL8和TGFβ升高与死于垂体疾病相关。
临床怎么用
- CD163巨噬细胞浸润、IL8和TGFβ水平可能作为侵袭性PitNET的预后生物标志物。
- 免疫微环境特征可能为侵袭性PitNET提供新的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: There is an ongoing need to identify prognostic and therapeutic biomarkers and develop alternative treatment options to treat aggressive and metastatic pituitary neuroendocrine tumours (PitNETs). This study aimed to examine the pituitary tumour immune microenvironment and correlate this with tumour behaviour to identify novel biomarkers. METHODS: This was a retrospective study of patients who underwent surgical resection of aggressive and non-aggressive PitNETs. Immune cells, immune checkpoints, and markers of cell cycle regulation and senescence were analysed using immunohistochemistry. Cytokines and chemokines were analysed using a multiplex immunoassay. RESULTS: Forty-eight PitNET samples were included in the study. 12 were classified as aggressive PitNETs (APT) and 3 died from pituitary disease. APTs compared with non-APTs had higher CD3 T lymphocyte and CD163 macrophage infiltrate as well as lower expression of IFN-γ and PDGFAA. On analysis of tumour types this was also observed in aggressive Pit1 PitNETs compared with SF1 PitNETs. Compared with SF1 PitNETs both aggressive and non-aggressive Pit1 PitNETs exhibited increased expression of checkpoint marker PDL1 and senescence markers p16 and p21. Pit1 and TPit PitNETs were more likely to demonstrate a perivascular pattern of immune cell infiltrate than SF1 PitNETs. MIG, MIP1β and IL1RA positively correlated with T lymphocytes, dendritic cells, and CD163 macrophages. Increased CD163 was associated with tumour recurrence, and increased IL8 and TGFβ was associated with death from pituitary disease. CONCLUSIONS: Aggressive PitNETs display a distinct tumour microenvironment characterised by increased immune cell infiltrate. These findings may offer novel prognostic biomarkers and therapeutic targets.
引用
- Lamb LS, Sim HW, Ramus SJ, et al. Aggressive pituitary neuroendocrine tumours display a distinct immune microenvironment. J Clin Endocrinol Metab. 2026. PMID: 42530027. doi:10.1210/clinem/dgag306
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。